Table 4.
Comparison of HCC characteristics based on the mode of HCC diagnosis
| Tumor characteristic | Overall (n = 1712) | Surveillance (n = 535) | Symptomatic (n = 1177) | P value |
|---|---|---|---|---|
| Numbers of lesion | ||||
| Single | 889 (52.7%) | 367 (69.5%) | 522 (45.0%) | <0.001 |
| Multiple/diffuse | 799 (47.3%) | 161 (30.5%) | 638 (55.0%) | |
| Tumor diameters (mm), median (IQR) | 36 (20–71) | 23 (16–38) | 56 (29–100) | <0.001 |
| Portal vein invasion | 480 (30.6%) | 36 (6.9%) | 444 (42.4%) | <0.001 |
| Lymph node involvement | 129 (8%) | 11 (2.1%) | 118 (10.8%) | <0.001 |
| Distant metastases | 174 (10.4%) | 3 (0.5%) | 171 (14.9%) | <0.001 |
| AFP, median (IQR) | 79 (8–4139) | 10.5 (4–46.2) | 520 (18–12 000) | <0.001 |
| BCLC | ||||
| 0/A | 467 (30.6%) | 341 (69.7%) | 126 (12.2%) | <0.001 |
| B/C/D | 1058 (69.4%) | 148 (30.3%) | 910 (87.8%) | |
| Treatment | ||||
| Curative | 532 (37.2%) | 350 (72.0%) | 182 (19.2%) | <0.001 |
| Non‐curative | 390 (27.2%) | 101 (20.8%) | 289 (30.6%) | |
| Best supportive care | 510 (35.6%) | 35 (7.2%) | 475 (50.2%) | |